Clinical Trials Browser

Phase 3 × oblimersen × Dermatologic × Clear all

NCT00016263 2014-01-06

Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma

Phase 3 Completed

Melanoma

NCT00518895 2011-11-07

AGENDA

Phase 3 Completed

Melanoma, Skin Neoplasms